KDM5A and inclusion body myositis: Comparing IBM patients' muscle tissue with healthy controls, we observed an increased percentage of myogenin‐positive myonuclei in IBM (p < 0.0001) that also showed increased KDM5A levels (p < 0.0001) (Figure 3C,D).